Developing A New Diagnostic Method For Alzheimer'S Disease

Abstract

Alzheimer's disease is the most common age-related neurodegenerative disease, and the most common cause of dementia. It is estimated that 212,000 Australians suffer from dementia and this will rise to approximately 730,000 by 2050. Currently there are no definitive diagnostic methods for AD. The research described in this application seeks to identify and validate a range of biomarkers identified in the blood of patients that would be suitable to use for diagnostic purposes.